Document is current
Any future updates will be listed below
-
Authors
Du, Mengxian
Guo, Fengyi
Liu, Xinna
Zhang, Shiqi
Zhang, Di
Qiu, Leyi
Zhang, Jingyang
Li, Baoqiang
Yuan, Huiping
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82070956)
Science and Technology Department, Heilongjiang Province (GA20C008)
- License Information
-
More Information
Article History
Received: 12 October 2025
Accepted: 16 February 2026
First Online: 23 February 2026
Declarations
:
: All methods were performed in accordance with the relevant guidelines and regulations. Animal protocols were approved by the Animal Ethics Committee (Project name: Study on the protective effect of rapamycin carbon dots on bone marrow Sca-1 + stem cell dominance recovery in aged OPTN (E50K) mice against RGC injury; Approval committee: the Animal Ethics Committee of Second Affiliated Hospital of Harbin Medical University; Approval number: YJSDW2024-055; Approval date: May 29th 2024)( Project name: Nano carbon dots for the treatment of glaucoma; Approval committee: the Animal Ethics Committee of Second Affiliated Hospital of Harbin Medical University; Approval number: SYDW2023-101; Approval date: December 29th 2023), which is carried out according to ARRIVE guidelines 2.0. This study does not involve human participants, therefore, obtaining informed consent for participation and publication is not applicable.
: The authors declare no competing interests.
